||EPS - Basic
||Market Cap (m)
Neutrahealth Share Discussion Threads
Showing 351 to 375 of 375 messages
|Indeed, less than half NAV per share.
However more than double NTAV per share.
Suggests some of that goodwill ought to have been written off !
I suspect not though, Elder obviously see value in underexploited assets.|
|Offer received of 6.5pps - hardly generous - 43% acceptances - let's pray for another interested party. BR.|
|suprised the lack of interest here|
|strange that the market discounted the bid today on no trades|
|results this week ? last year they were on September 15th, BR.|
|holding nice and firm here for now, ready for the next push on results i reckon|
|homewell, i think that if the results and outlook stack up, we should be looking at 8p here considering there is no weight on the sp|
|either way homewell he must be expecting some decent interims increasing his position by that amount 15 dyas or so results are due. am getting quite excited now|
|and who are the 8% Hills?
|interims due mid september, should be interesting to see their growth|
|edging up pre results. Remember chance of a divi as Mr Myers commented in the last statement.
Quiet accumulation on PLUS as well. Here's to a revival in the share price|
|There is a feature on NUT here...
You may need to sign up but it is easy and free.|
|delayed buy trade being reported today of 1 million, cause of Friday's tick up.|
|10p short term...|
|Highest for 18 months after a very strong rise today - perhaps we shall see an announcement later re the price movement. BR.|
|Any idea as to what's happening today?|
|RNS Number : 7391Z
28 September 2009
28 September 2009
NEUTRAHEALTH PLC ('the Company')
ISSUE OF SHARE OPTIONS
NeutraHealth plc, one of the leading UK vitamins & supplements companies, today announces that it has re-issued share options to the Executive Directors.
The Board considered that the 9,570,369 share options in issue to the Executive Directors with strike prices of between 10p and 13.5p did not sufficiently incentivise performance in the interests of shareholders, and had unrealistic performance conditions given the current market environment.
The number of options cancelled and reissued for Executive Directors are as follows
Number of cancelled options Strike price Number of reissued options New strike price % of Ordinary Share Capital
10p 5,200,000 4.25p 3.0
Robin Hilton 1,666,666 13.5p 3,666,666
703,703 13.5p 2,703,703 4.25p 1.5
The options detailed above are the only options in issue for the named directors.
The options are exercisable in whole or in part two years after being granted and are subject to a minimum adjusted earnings per share of 1.0p being reached and a minimum share price of 6p per share. Adjusted earnings per share excludes the effect of any significant one off items, share options charges, and amortisation of intangible assets arising on acquisition. The adjustments are detailed in the Annual Report each year. The adjusted earnings per share performance condition does not apply on change of control of the business. The options will lapse if not exercised within ten years of the date of grant. The grant was made on 25 September 2009.
Following the grant of options, the aggregate number of Ordinary Shares under option pursuant to any Company option scheme is within the limit described further in the admission document relating to the re-admission of NeutraHealth to AIM on 31 August 2005 following completion of the acquisition of BioCare Limited. The total number of options over Ordinary Shares which have been granted pursuant to the Company's option schemes is 17,736,773 and the number of new shares issuable pursuant to such options represents 10.1% of the Company's issued Ordinary Share capital. These include options over 1,404,500 Ordinary shares representing 0.8% of the Company's issued Ordinary Share capital which are exempt from the limits described in the admission document referred to above.|
|4 mill buy yesterday|
|NUT seem to be missing out on the market rally in small caps over the summer, surprising since their most recent trading statement was positive. Results out next Tuesday so I guess we'll find out more then.|
|Yes, I agree!. However, at least Rensburg Shepherd who have been sellers for months and thereby depressing the share price, are now no longer holders as a result.|
|most bizarre.....oil and neutraceuticals....can't get much more unrelated than that.|
|Looks like this Thalassa Holdings could be an alternative suitor for Neutrahealth - from their recent annual report:
"The current economic crisis looks to be worse than expected and recovery may take longer than people anticipate. Whilst this situation has definite negative short term implications, there is no doubt that crisis also represents opportunity and with this in mind your Board is looking at all alternatives to grow shareholder value, including but not limited to the acquisition, integration or development of businesses which the directors consider to have potential for capital growth or any other strategic initiatives."
"The Board has also sought to clarify the strategy set out in the Admission Document dated 23 July 2008 by including a resolution to be put to the shareholders at the Annual General Meeting which provides that the strategy of the Company will include activities unrelated to the energy industry. "|
|If Elder Pharma want to take NUTs home, they need to be bidding 7p minimum. The partial offer to acquire up to 40% more of the equity at or around 5.5p was not welcomed by the shareholders.
Given trading is improving and costs reducing, the price needs to compensate for better fundamentals.
Elder continue to review their options and the share price seems detached from the likely bid outcome.|
|Something going on here imo.|